Clinical utility of 18-fluorodeoxyglucose positron emission tomography/computed tomography in malignant pleural mesothelioma

By              

Experimental and Therapeutic Medicine, Vol. 4, Iss. 2, 2012-01 ,pp. : 197-200

Spandidos Publications

Access to resources Recommend Favorite

Chemotherapy for Malignant Pleural Mesothelioma

By Garland Linda  

Current Treatment Options in Oncology, Vol. 12, Iss. 2, 2011-06 ,pp. : 181-188

Springer Publishing Company

Access to resources Recommend Favorite

Clinical implications of 18F-fluorodeoxyglucose positron emission tomography/computed tomography at delayed phase for diagnosis and prognosis of malignant pleural mesothelioma

By                      

Oncology Reports, Vol. 27, Iss. 2, 2012-01 ,pp. : 333-338

Spandidos Publications

Access to resources Recommend Favorite

Evaluation of good clinical response to neoadjuvant chemotherapy in primary breast cancer using [ 18 F]-fluorodeoxyglucose positron emission tomography

By Burcombe R.J.   Makris A.   Pittam M.   Lowe J.   Emmott J.   Wong W.L.  

European Journal of Cancer, Vol. 38, Iss. 3, 2002-01 ,pp. : 375-379

Elsevier

Access to resources Recommend Favorite

Determinants of Response to Neoadjuvant Chemotherapy for Esophageal Cancer Using ¹⁸F-fluorodeoxiglucose Positron Emission Tomography (¹⁸F-FDG-PET)

By Miyata Hiroshi   Yamasaki Makoto   Takahashi Tsuyoshi   Murakami Kohei   Tanaka Koji   Yukinori Kurokawa   Nakajima Kiyokazu   Takiguchi Shuji   Morii Eiichi   Hatazawa Jun   Mori Masaki   Doki Yuichiro  

Annals of Surgical Oncology, Vol. 21, Iss. 2, 2014-02 ,pp. : 575-582

Springer Publishing Company

Access to resources Recommend Favorite